VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2020 | Radioligand therapy advancements in prostate cancer

Jeremie Calais, MD, University of California, Los Angeles, CA, outlines advancements in radioligand therapy in prostate cancer, specifically talking on Lutetium-labelled PSMA, the refinements required and exciting upcoming data. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter